Pleural mesothelioma’s aggressive nature and complex anatomical considerations often limit treatment options; hence, surgery’s role remains contentious. The recent study from Mount Sinai counters the skepticism generated by the Mesothelioma and Radical Surgery 2 (MARS2) trial, conducted in 2024, which questioned the value and safety of radical surgical interventions. Unlike MARS2, where higher early postoperative mortality rates were reported, the Mount Sinai cohort experienced zero in-hospital and 30-day mortality and only a 4.2 percent mortality rate at 90 days post-surgery. This stark contrast elucidates the critical role of patient selection, surgical technique refinement, and comprehensive preoperative evaluation.

At the heart of this study’s success is the surgical technique of pleurectomy/decortication. This procedure intricately removes the diseased pleural lining and tumor masses while sparing the underlying lung parenchyma, thereby preserving pulmonary function. Such an approach significantly reduces surgical morbidity compared to extrapleural pneumonectomy, an older, more radical operation that entails removing the lung along with the pleura, diaphragm, and pericardium. Mount Sinai’s data reinforce that organ preservation should be prioritized where feasible, as it offers a meaningful balance between oncologic control and patient quality of life.

The study’s senior author, Dr. Raja M. Flores, a distinguished Professor of Surgery and Chair of Thoracic Surgery at Mount Sinai, underscores that the outcomes hinge not merely on the surgical procedure itself but on the nuanced selection of appropriate candidates. Over nearly two decades, Dr. Flores has been a pioneer in thoracic oncology research, having previously demonstrated that pleurectomy/decortication confers superior survival benefits when compared to more extensive surgeries in mesothelioma patients. This trajectory reflects an evolving understanding of mesothelioma surgery from purely oncologic aggressiveness toward personalized, patient-centric care.

Integral to these improved outcomes is the use of advanced imaging modalities and rigorous preoperative screening protocols. Modern diagnostic imaging enables precise tumor staging and identification of the epithelioid subtype of mesothelioma, which comprised nearly 80 percent of patients in the Mount Sinai cohort. This histologic subtype is associated with better surgical outcomes, and its prevalence likely influenced the favorable postoperative mortality observed. Furthermore, the study excluded patients considered for extrapleural pneumonectomy, thereby focusing on a population more amenable to lung-sparing surgery and less susceptible to severe surgical complications.

This paradigm shift reflects a broader transformation within thoracic oncology, wherein surgical candidacy is now contingent on multidimensional patient evaluation encompassing functional status, tumor biology, and individual risk profiles. Mount Sinai’s meticulous approach includes rigorous pulmonary and cardiac assessments, ensuring only those patients who can tolerate the extensive surgical procedure and recovery are offered pleurectomy/decortication. This tailored methodology contrasts with earlier trials like MARS2 and may account for divergent outcomes and interpretations regarding surgery’s efficacy.

An important contextual element is mesothelioma’s overarching clinical challenge: its limited responsiveness to traditional therapeutic modalities such as chemotherapy and radiation. This therapeutic void accentuates the urgency for surgical innovation that can safely extend survival and maintain quality of life. The Mount Sinai study, therefore, represents a significant advance by not only supporting surgery’s potential role but also establishing new benchmarks for its implementation in multidisciplinary treatment regimens.

The implications of these findings extend beyond immediate surgical outcomes. The team at Mount Sinai is currently exploring the integration of immunotherapy with surgical strategies to further enhance treatment efficacy. Preliminary investigations suggest that combining lung-sparing surgery with immune checkpoint inhibitors could potentiate anti-tumor responses, offering a promising frontier in mesothelioma management. This ongoing research underscores the institution’s commitment to translating benchside discoveries into clinical realities with tangible patient benefits.

Another notable aspect of Mount Sinai’s legacy in mesothelioma research is its historical link to Dr. Irving J. Selikoff, whose pioneering studies first established asbestos exposure as the etiologic agent in mesothelioma. His work catalyzed regulatory policies that curtailed asbestos use worldwide, thereby offering primary prevention. Today, Mount Sinai continues this legacy through comprehensive patient care programs, including those addressing mesothelioma cases linked to environmental exposures such as the World Trade Center disaster.

The study’s findings, emphasizing safety and tailored surgical care, offer renewed hope to patients and clinicians navigating the difficult terrain of pleural mesothelioma treatment. Dr. Flores articulates the essential message succinctly: while surgery may not be suitable for every patient, for carefully selected individuals at experienced centers, it remains a vital and viable path to prolonged survival. This perspective advocates for surgical consideration to remain a pivotal component of mesothelioma care discussions.

In conclusion, these contemporary outcomes from Mount Sinai challenge the prevailing skepticism about the surgical management of pleural mesothelioma. They underscore that with state-of-the-art imaging, stringent patient selection, and lung-preserving techniques, pleurectomy/decortication can be safely employed with minimum early mortality and optimal therapeutic benefit. This study not only advances surgical science but also offers a beacon for evidence-based, patient-centered oncology in the face of one of the most daunting thoracic malignancies.

Subject of Research: People

Article Title: Disaster on MARS2? Lessons Learned from Modern Day Outcomes of Surgery for Pleural Mesothelioma

News Publication Date: 2-Feb-2026

Web References:

• DOI: 10.1016/j.athoracsur.2026.01.025
• MARS2 trial full text: The Lancet Respiratory Medicine

Image Credits: Mount Sinai Health System

Keywords: Mesothelioma, Lung cancer

Textiloma, also interchangeably labeled as gossypiboma, arises from the accidental retention of textile materials such as surgical sponges or towels during operative procedures. Despite rigorous surgical protocols designed to prevent such outcomes, incidents persist, endangering patient safety and provoking complex litigation scenarios. The pathophysiology of textiloma involves a chronic foreign body reaction incited by retained textile matter, manifesting as fibrotic encapsulation or abscess formation. These biological responses often result in a spectrum of clinical presentations, ranging from asymptomatic masses to severe inflammatory complications, posing diagnostic dilemmas even decades after surgery.

The case report highlighted in the study involved a patient who underwent abdominal surgery and later developed unexplained symptoms including pain, palpable masses, and intermittent infections. Initial clinical and radiological assessments failed to pinpoint the etiology of these manifestations until advanced imaging revealed a suspicious encapsulated mass consistent with a retained surgical textile. The surgical team’s discovery of a gossypiboma during the subsequent intervention not only resolved the patient’s condition but also underscored the latent nature of textilomas, which can remain dormant before erupting into severe clinical syndromes.

From a forensic perspective, the occurrence of textiloma transcends medical consequences to occupy a critical role in legal medicine. The failure to adhere to standardized surgical counts and safety checklists constitutes clear-cut evidence of negligence, subject to judicial scrutiny and malpractice claims. Furthermore, the identification of textiloma via radiological or pathological means demands precise documentation and expert testimony to unravel the circumstances under which the foreign object was retained. The reviewed literature emphasizes the necessity of multidisciplinary cooperation among surgeons, radiologists, pathologists, and forensic experts to achieve accurate diagnosis and conclusive medicolegal evaluations.

Radiologically, the identification of a textiloma relies heavily on imaging modalities such as computed tomography (CT) scans, magnetic resonance imaging (MRI), and ultrasound. These techniques divulge characteristic signs including spongiform patterns, calcifications, or well-defined encapsulated masses often accompanied by gas bubbles or fluid collections. Nonetheless, these indicators may mimic neoplastic or infectious lesions, complicating differential diagnosis. The article stresses the need for heightened suspicion and awareness among radiologists to consider retained textile materials in post-operative patients presenting with unexplained masses or inflammatory symptoms.

The implications extend beyond the single patient, impacting surgical teams and hospital systems globally. The persistence of textiloma cases signifies systemic shortcomings in surgical safety protocols, particularly the implementation and verification of count procedures for sponges and instruments. Modern technological advancements, including radiofrequency identification (RFID) tags embedded in surgical textiles, are proposed as adjunctive preventive measures. However, their widespread adoption is hindered by cost and infrastructural challenges, reflecting an ongoing tension between technological potential and practical clinical usage.

Clinically, the management of textiloma necessitates surgical removal once identified, as retained foreign bodies invariably precipitate pathological inflammatory reactions with potential for fistula formation, abscesses, or sepsis. The surgical extraction, while curative, carries risks associated with re-operation and anesthesia, emphasizing the primacy of prevention over treatment. Postoperative follow-up demands vigilance for recurrence or complications arising from the foreign body reaction itself. The case reviewed demonstrated favorable outcomes due to timely diagnosis and intervention, serving as a cautionary tale about delays in managing such potentially catastrophic iatrogenic conditions.

The article’s review draws attention to the psychosocial and medicolegal trauma inflicted on patients suffering from textiloma. Beyond physical complications, patients often endure psychological distress stemming from mistrust towards the healthcare system and prolonged diagnostic uncertainty. Legal battles ensuing from these episodes strain both patients and providers, prompting calls for transparent institutional policies and support mechanisms. Ethical considerations about disclosure and consent after identification of retained surgical items also demand rigorous discussion within medical communities.

Moreover, the forensic dimension extends into post-mortem examinations where undetected textilomas may confound cause-of-death analyses. Autopsy findings of retained surgical textiles necessitate careful differentiation from pathological masses or traumatic injuries. For forensic pathologists, awareness of the characteristic gross and microscopic features of textilomas is essential to establish timelines and reconstruct clinical histories pertinent to legal inquiries. The study’s extensive literature review complements these forensic challenges by aggregating data that reinforce the indispensable role of pathology in medico-legal determinations of surgical negligence.

This comprehensive exploration underscores a critical need for policy reforms aimed at mitigating textiloma incidence. Institutional adherence to surgical safety checklists, continuous education of operating room personnel, and incorporation of cutting-edge technological tools constitute pivotal strategies. National healthcare systems must prioritize quality control mechanisms and root cause analyses following textiloma identification to forestall recurrence and uphold patient safety standards. Integration of forensic oversight into healthcare audits may enhance accountability and transparency, fostering an environment resistant to such preventable errors.

In summary, the phenomenon of textiloma represents a confluence of surgical, clinical, forensic, and legal complexities that demand multidisciplinary attention. The 2025 publication by De Paola and associates serves not merely as a clinical case report but as a clarion call to the global medical community regarding the dire consequences of surgical negligence. With patient lives and legal ramifications intertwined, confronting the challenge of textiloma requires an unwavering commitment to safety, precision, and ethical responsibility at every step of surgical care.

As surgical techniques advance and patient safety remains paramount, tackling the invisible threat of retained surgical textiles will continue to be a crucial aspect of both operative practice and forensic investigation. The reviewed case and literature encapsulate this ongoing struggle and spotlight opportunities for innovation and systemic improvement. Ultimately, preventing textiloma transcends mere error elimination—it embodies the holistic ethos of healthcare excellence dedicated to protecting patients from harm at all costs.

Subject of Research: Surgical retention of foreign textile materials (textiloma/gossypiboma), its clinical presentation, diagnosis, treatment, and forensic-medical implications related to medical negligence.

Article Title: Textiloma: surgical and forensic implications of medical negligence. A case report and literature review.

Article References:
De Paola, L., Napoletano, G., Cirillo, B. et al. Textiloma: surgical and forensic implications of medical negligence. A case report and literature review. Int J Legal Med (2025). https://doi.org/10.1007/s00414-025-03547-6

Image Credits: AI Generated